|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/536 | |
| A61P 11/06 |
| (11) | Number of the document | 1809293 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05747843.0 |
| Date of filing the European patent application | 2005-05-10 | |
| (97) | Date of publication of the European application | 2007-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/005028 |
| Date | 2005-05-10 |
| (87) | Number | WO 2005/110421 |
| Date | 2005-11-24 |
| (30) | Number | Date | Country code |
| 102004024452 | 2004-05-14 | DE |
| (72) |
AVEN, Michael, DE
|
| (73) |
Boehringer Ingelheim Pharma GmbH & Co. KG,
Binger Strasse 173, 55216 Ingelheim,
DE
BOEHRINGER INGELHEIM INTERNATIONAL GMBH, Binger Str. 173, 55216 Ingelheim, DE |
| (54) | AEROSOLFORMULIERUNG FÜR DIE INHALATION VON BETAAGONISTEN |
| AEROSOL FORMULATION FOR INHALATION OF BETA AGONISTS |